Financial Analysis
Filing-based analysis. Market pricing is not included. Fundamentals from SEC filings; economic data from FRED and the BLS. About our data
Filing evidence summary
Mixed evidenceCoverage 5/5 core metricsLatest reported free cash flow was -$729,406.
Backward-looking filed evidence under visible rules - not a rating, forecast or investment advice. Missing data is never scored.
Evidence signals
- Free cash flow was negative
Latest reported free cash flow was -$729,406.
Why this surfaced
Free cash flow = operating cash flow minus capital expenditures; positive is supporting evidence, not a valuation conclusion. Period end 2025-12-31.
- Shareholders' equity was non-positive
Debt/equity is shown as not meaningful rather than as a negative leverage ratio.
Why this surfaced
Same-period reported shareholders' equity was zero or negative; review the balance sheet and capital structure. Period end 2025-12-31.
- 4 filing risk checks flagged
Flagged areas: Solvency & liquidity.
Why this surfaced
The full financial analysis shows each value, threshold, and sector limitation.
- Revenue was broadly stable
Latest reported annual revenue changed +1.3% from the prior reported annual observation.
Why this surfaced
Direction threshold: above +2% constructive; below -2% caution; otherwise monitor. This is not labeled one-year growth when filing periods have a gap. Period end 2025-12-31.
- Operating margin improved
Operating margin changed +23.9 percentage points from the prior annual period.
Why this surfaced
Direction threshold: more than +1 percentage point constructive; below -1 point caution. Period end 2025-12-31.
Core trend metrics
Hover a tile for its exact definition; the Statements tab carries per-cell filing citations.
Where to look next
Risk checks
- Solvency & liquidity
Financial movement
- Cash→ flat
- Long-term debt→ flat
- Inventory→ flat
- Receivables→ flat
- Current assets→ flat
Source & freshness
- Source
- SEC EDGAR XBRL
- Fetched
- 2026-09-06
- Latest period end
- 2025-12-31
- Filings
- EDGAR ↗
Reported segment mix
figures as filed · share of the filed sum · change vs the prior period in the same filing- Product Revenue$14.2Mshare n/a-1.7% yoy
- License Revenue$3.16Mshare n/a+12.5% yoy
- License$3.13Mshare n/a+12.7% yoy
- Equipment Revenue$141Kshare n/a+75.3% yoy
- Demonstrations Consulting Revenue$93.2Kshare n/a+158.8% yoy
member sum exceeds the consolidated figure: this axis carries more than one breakdown, so shares are not computed.
- Product Revenue$4.19M98.8%+56.4% yoy
- Equipment Revenue$28.6K0.7%+185.4% yoy
- Demonstrations Consulting Revenue$23.4K0.6%+160.0% yoy
- License Revenue$00.0%-100.0% yoy
- License$00.0%-100.0% yoy
Change is against the same quarter a year earlier, as reported in the same 10-Q.
Source: SEC DERA Financial Statement and Notes data sets. Dimensional XBRL facts on the business-segment, product/service and geographic axes; the engine keeps the accession of every figure. Descriptive and educational, not advice.
Peer percentiles
latest fiscal year ending 2025-12-31 · among 4,122 US-listed filers · 318 in Healthcare| Metric | Value | vs all filers | vs sector |
|---|---|---|---|
Revenue latest fiscal-year revenue as filed | $18M | 14thof 3,301 bottom third | 17thof 291 bottom third |
Revenue growth latest fiscal-year revenue vs the prior fiscal year | 1.3% | 33rdof 3,135 bottom third | 26thof 277 bottom third |
Gross margin gross profit ÷ revenue | 42.0% | 56thof 1,603 middle third | 27thof 212 bottom third |
Operating margin operating income ÷ revenue | -17.2% | 28thof 2,819 bottom third | 39thof 280 middle third |
Net margin net income ÷ revenue | -17.2% | 26thof 3,263 bottom third | 39thof 290 middle third |
Free-cash-flow margin (operating cash flow − |capex|) ÷ revenue | -4.1% | 28thof 2,679 bottom third | 40thof 261 middle third |
Interest coverage operating income ÷ interest expense (interest expense > 0) | -221.6× | 6thof 819 bottom third | 10thof 76 bottom third |
Stock comp ÷ revenue stock-based compensation ÷ revenue · lower is ranked higher | 0.7% | 78thof 2,895 top third | 91stof 272 top third |
Days sales outstanding receivables ÷ revenue × 365 · lower is ranked higher | 43 days | 57thof 2,398 middle third | 78thof 266 top third |
Cash-flow accrual ratio (net income − operating cash flow) ÷ average total assets · lower is ranked higher | -23.9% | 92ndof 3,577 top third | 91stof 272 top third |
Balance-sheet accrual ratio change in net operating assets ÷ average net operating assets · lower is ranked higher | 51.6% | 16thof 3,059 bottom third | 15thof 237 bottom third |
Each filer's latest fiscal year as stored by the nightly crawl; fiscal year ends differ across the universe. A metric ranks only filers for which it is computable from filed facts. Ties split; a rank reads "better than N% of filers" in the metric's own direction. Descriptive and educational, not a rating.
Earnings quality
latest fiscal year ending 2025-12-31 · accruals and cash conversion as filedPer fiscal year from filed facts: cash conversion = operating cash flow / net income (net income > 0); cash-flow accrual ratio = (net income - operating cash flow) / average total assets; balance-sheet accrual ratio = change in net operating assets / average net operating assets, NOA = (assets - cash) - (liabilities - debt). Descriptive; a missing input yields a missing ratio. High accrual ratios and cash conversion well below one are the measures the accruals literature associates with less persistent earnings; they are screens to read the cash-flow statement with, not conclusions. The per-year series is part of Pro risk analysis.
Point-in-time ledger
first-reported vs latest filing · periods since 2020-01-01 · 27 changed periods, 26 largest shown| Line item | Period | First reported | Latest filing | Change | Filings |
|---|---|---|---|---|---|
| Interest expense InterestExpense | quarter 2021-06-30 | $10.3K 10-Q 2021-08-16 | $1.12M 10-Q 2022-08-15 | +10772.5% | first · latest |
| Interest expense InterestExpense | fiscal year 2021-12-31 | $41.3K 10-K 2022-04-05 | $2.82M 10-K 2023-05-15 | +6719.9% | first · latest · 3 filings carry it |
| Interest expense InterestExpense | quarter 2021-09-30 | $10.2K 10-Q 2021-11-15 | $507K 10-Q 2022-11-14 | +4859.3% | first · latest |
| Interest expense InterestExpense | quarter 2021-03-31 | $10.2K 10-Q 2021-05-17 | $487K 10-Q 2022-05-18 | +4684.8% | first · latest |
| Debt issued ProceedsFromNotesPayable | fiscal year 2021-12-31 | $32.8K 10-K 2022-04-05 | $299K 10-K 2023-05-15 | +813.1% | first · latest |
| Operating cash flow NetCashProvidedByUsedInOperatingActivities | fiscal year 2021-12-31 | $206K 10-K 2022-04-05 | -$206K 10-K 2023-05-15 | -200.0% | first · latest |
| Debt issued ProceedsFromNotesPayable | fiscal year 2020-12-31 | -$165K 10-K 2021-04-05 | $165K 10-K 2022-04-05 | +200.0% | first · latest |
| Debt issued ProceedsFromNotesPayable | quarter 2021-03-31 | -$34.7K 10-Q 2021-05-17 | $34.7K 10-Q 2022-05-18 | +200.0% | first · latest |
| Stockholders' equity StockholdersEquity | balance at 2023-12-31 | -$783K 10-K 2024-04-16 | $60.4K 10-K 2026-03-31 | +107.7% | first · latest · 9 filings carry it |
| Stock-based compensation ShareBasedCompensation | quarter 2020-03-31 | $115K 10-Q 2020-07-06 | $0 10-Q 2021-05-17 | -100.0% | first · latest |
| Receivables AccountsReceivableNetCurrent | balance at 2023-12-31 | $2.23M 10-K 2024-04-16 | $3.08M 10-K 2025-03-31 | +37.8% | first · latest · 5 filings carry it |
| Stockholders' equity StockholdersEquity | balance at 2024-09-30 | $1.91M 10-Q 2024-11-14 | $2.49M 10-Q 2025-11-13 | +29.9% | first · latest |
| Stockholders' equity StockholdersEquity | balance at 2024-06-30 | $2.23M 10-Q 2024-08-12 | $2.79M 10-Q 2025-11-13 | +25.1% | first · latest · 4 filings carry it |
| Gross profit GrossProfit | quarter 2024-03-31 | $1.44M 10-Q 2024-05-15 | $1.13M 10-Q 2025-05-15 | -21.8% | first · latest |
| Operating income OperatingIncomeLoss | quarter 2024-03-31 | -$2.08M 10-Q 2024-05-15 | -$2.4M 10-Q 2025-05-15 | -15.1% | first · latest |
| Gross profit GrossProfit | fiscal year 2022-12-31 | $6.1M 10-K 2023-05-15 | $7.02M 10-K 2024-04-16 | +15.1% | first · latest |
| Net income NetIncomeLoss | quarter 2024-03-31 | -$2.56M 10-Q 2024-05-15 | -$2.85M 10-Q 2025-11-13 | -11.6% | first · latest · 6 filings carry it |
| Interest expense InterestExpense | quarter 2022-03-31 | $457K 10-Q 2022-05-18 | $498K 10-Q 2023-06-06 | +8.9% | first · latest |
| Revenue Revenues | quarter 2024-03-31 | $3.56M 10-Q 2024-05-15 | $3.24M 10-Q 2025-05-15 | -8.9% | first · latest |
| Stockholders' equity StockholdersEquity | balance at 2024-03-31 | $8.26M 10-Q 2024-05-15 | $8.8M 10-Q 2025-11-13 | +6.6% | first · latest · 6 filings carry it |
| Gross profit GrossProfit | fiscal year 2023-12-31 | $5.77M 10-K 2024-04-16 | $5.45M 10-K 2025-03-31 | -5.5% | first · latest |
| Net income NetIncomeLoss | fiscal year 2023-12-31 | $5.9M 10-K 2024-04-16 | $5.67M 10-K 2025-03-31 | -4.0% | first · latest |
| Operating income OperatingIncomeLoss | fiscal year 2023-12-31 | -$8.66M 10-K 2024-04-16 | -$8.97M 10-K 2025-03-31 | -3.6% | first · latest |
| Total assets Assets | balance at 2023-12-31 | $27.5M 10-K 2024-04-16 | $28.3M 10-K 2025-03-31 | +3.1% | first · latest · 5 filings carry it |
| Net income NetIncomeLoss | quarter 2024-09-30 | -$470K 10-Q 2024-11-14 | -$458K 10-Q 2025-11-13 | +2.7% | first · latest |
| Interest expense InterestExpense | quarter 2020-09-30 | $10.2K 10-Q 2020-11-23 | $10.4K 10-Q 2021-11-15 | +2.0% | first · latest |
4 share-count periods re-presented for a stock split (1-for-5) are listed apart from restatements and not counted above.
First filing reporting each period vs the latest filing carrying it (10-K and 10-Q only, periods since 2020, the extractor's winning tag per concept); a change under 0.5% is treated as rounding. A change can be a restatement, a reclassification or a re-tagging in a later comparative column; the two filings are linked so the reader can see which. Descriptive, not a verdict.
Notes by disclosure type
Not available for BCHT yet: no footnote text blocks on file for this filer in the ingested DERA files.
Fundamentals from SEC EDGAR. Scores, the DCF, and every model shown are educational analysis, not investment advice or price predictions.